InterVenn Biosciences
PrivateLast Round
Series C
Aug 2, 2021
Total Funding Raised
$244.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
InterVenn Biosciences is a biotechnology company that develops an AI-powered platform for glycoproteomic analysis to enhance early cancer detection and precision medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InterVenn Biosciences Comparables
Compare InterVenn Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PrognomiQ | 82% | |
| AOA Dx | 79% | |
| Harbinger Health | 78% |
InterVenn Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 2, 2021 | ||||
| Series B | Nov 16, 2020 | ||||
| Series A | Dec 12, 2018 |
InterVenn Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xeraya Capital | Series B, Series C |
| Ojjeh Family | Series B |
| Highside Capital Management | Series C |
| Prado SV | Series A |
| SoftBank Group | Series C |
| Genoa Ventures | Series B, Series C, Series A |
| Irving Investors | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 64% MoM, reaching 2.6K.
- Jul 25, 2026
Monthly visitors increased 46% MoM.
InterVenn Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about InterVenn Biosciences's valuation, stock price, and market status.
Is InterVenn a public or private company?
InterVenn is a private company.
What is the current stock price of InterVenn?
InterVenn is a private company with no public stock price. No recent secondary market data is available.
How much is InterVenn worth (valuation)?
Valuation information for InterVenn is not publicly available.
Can I buy InterVenn stock?
InterVenn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was InterVenn's last funding round?
InterVenn's most recent funding round was Series C on August 2, 2021.
Who are the main investors in InterVenn?
Key investors in InterVenn include SoftBank Group, Genoa Ventures, Anzu Partners, HIGHSIDE Global.
Will InterVenn IPO soon?
No public IPO plans have been announced for InterVenn.
How can I track InterVenn secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor InterVenn's secondary market activity and sign up for updates.